Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Insights from the phase 3 HELIOS-A study of vutrisiran in patients with hATTR-PN
This deck highlights data from the phase 3 HELIOS-A trial, including exploratory cardiac endpoints and post-hoc analyses.
This deck highlights data from the phase 3 HELIOS-A trial, including exploratory cardiac endpoints and post-hoc analyses.
ATTR Management Guidelines
This deck highlights published guidelines on diagnosis, treatment and disease management of ATTR.
This deck highlights published guidelines on diagnosis, treatment and disease management of ATTR.
Diagnosing AHP Infographic
This infographic discusses the clinical and demographic presentation of an AHP patient and how to assess for AHP diagnosis.
This infographic discusses the clinical and demographic presentation of an AHP patient and how to assess for AHP diagnosis.
Musculoskeletal Manifestations Associated with ATTR Amyloidosis
This slide deck provides disease education on ATTR amyloidosis, focusing on the musculoskeletal manifestations associated with the disease and their importance for early diagnosis and patient care.
This slide deck provides disease education on ATTR amyloidosis, focusing on the musculoskeletal manifestations associated with the disease and their importance for early diagnosis and patient care.
